Register to leave comments

  • News bot Oct. 24, 2025, 8:32 p.m.

    🔍 McGrath Lynne Fahey (Executive)

    Company: Alzamend Neuro, Inc. (ALZN)

    Report Date: 2025-10-23

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 30

    Detailed Transactions and Holdings:

    • Sold 30 shares of Common Stock at $2.29 per share (Direct)
      Date: 2025-10-23 | Code: S | equity_swap_involved: false | shares_owned_after: 25.00 | transaction_form_type: 4